Bolt Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.About BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs.
CEOWilliam P. Quinn
CEOWilliam P. Quinn
Employees52
Employees52
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2015
Founded2015
Employees52
Employees52
BOLT Key Statistics
Market cap9.60M
Market cap9.60M
Price-Earnings ratio-0.22
Price-Earnings ratio-0.22
Dividend yield—
Dividend yield—
Average volume34.63K
Average volume34.63K
High today$5.21
High today$5.21
Low today$4.93
Low today$4.93
Open price$4.93
Open price$4.93
Volume21.91K
Volume21.91K
52 Week high$10.50
52 Week high$10.50
52 Week low$4.41
52 Week low$4.41
Stock Snapshot
With a market cap of 9.6M, Bolt Biotherapeutics(BOLT) trades at $4.95. The stock has a price-to-earnings ratio of -0.22.
During the trading session on 2026-02-14, Bolt Biotherapeutics(BOLT) shares reached a daily high of $5.21 and a low of $4.93. At a current price of $4.95, the stock is +0.4% higher than the low and still -5.0% under the high.
Trading volume for Bolt Biotherapeutics(BOLT) stock has reached 21.91K, versus its average volume of 34.63K.
Over the past 52 weeks, Bolt Biotherapeutics(BOLT) stock has traded between a high of $10.50 and a low of $4.41.
Over the past 52 weeks, Bolt Biotherapeutics(BOLT) stock has traded between a high of $10.50 and a low of $4.41.
People also own
Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.